Dr. Christopher M. Glinkerman is a Ph.D. chemist with a passion for translating cutting-edge science into real-world solutions. He has contributed to scientific initiatives at innovative biotech companies including 1859 Inc. and Zafrens, where he designed and built one-bead-one-compound (OBOC) DNA-encoded libraries (DELs), advanced cheminformatics pipelines, and supported the progression of several drug discovery programs. With expertise in synthetic chemistry, DEL technology, and computational drug design, Dr. Glinkerman brings a rare blend of hands-on laboratory experience and data-driven insight to every collaboration.

 

Dr. Glinkerman earned his Ph.D. in chemistry from The Scripps Research Institute and completed postdoctoral training at the Whitehead Institute for Biomedical Research.